Related Experiment Videos
Clomipramine treatment of panic disorder: pros and cons
L A Papp1, F R Schneier, A J Fyer
1New York State Psychiatric Institute, NY 10032, USA.
Background:
Controlled trials suggest that clomipramine may be a highly effective antipanic drug. Lowering the starting dose may alleviate troublesome initial side effects and increase acceptability and compliance.
Method:
Fifty-eight patients with DSM-III-R panic disorder with or without agoraphobia underwent 13 weeks of clomipramine treatment. Starting at 10 mg/day, the dose was gradually increased to a mean dose of 97 mg/day.
Results:
While completers showed highly significant improvement, the benefits were severely limited by a high dropout rate due to adverse reactions occurring mostly during the first 2 weeks of treatment.
Conclusion:
Given the alternatives, clomipramine should not be used as a first-line antipanic medication.